Harm potential: YELLOW—True iron deficiency anemia requires supplementation.
Evidence map4 cited passagesInspect provenance +
Iron catalyzes Fenton reactions (Fe2+ + H2O2 → Fe3+ + OH- + OH-) generating hydroxyl radicals that damage dopaminergic neurons. Polyphenols' therapeutic benefit in schizophrenia derives partly from iron chelation—reducing iron-mediated oxidative stress. The therapeutic direction is iron restriction, not supplementation.
Enterobacteriaceae are significantly enriched in schizophrenia (systematic review of 30 studies, ). These organisms produce siderophores for iron scavenging. Supplemental iron feeds this competitive advantage, worsening the dysbiotic bloom and increasing LPS production.
With 28% of schizophrenia patients showing elevated CRP (OR 1.5 for psychosis, ), low serum iron may represent hepcidin-mediated iron sequestration—a host defense mechanism to starve iron-dependent pathogens. Supplementing iron in this context overrides the host's own defense strategy.
Consider polyphenol supplementation (curcumin, EGCG, quercetin) for therapeutic iron chelation.
Contents
1. When This STOP Does NOT Apply2. When This STOP Applies3. The Conventional Approach4. Why This Is Counterproductive5. Alternative ApproachWhen This STOP Does NOT Apply#
True iron deficiency anemia with low ferritin AND low CRP (genuine depletion, not sequestration). Acute blood loss or other causes of absolute iron deficiency. Symptomatic anemia with hemoglobin <10 g/dL—treat the anemia while investigating inflammatory status.
When This STOP Applies#
Patient has schizophrenia AND elevated inflammatory markers (CRP, IL-6, sCD14). Low serum iron in the context of chronic inflammation. Fatigue attributed to anemia without ruling out functional iron deficiency (anemia of chronic disease).
The Conventional Approach#
Schizophrenia patients frequently present with fatigue, cognitive dulling, and blood markers suggestive of anemia. The conventional reflex is iron supplementation.
Why This Is Counterproductive#
Three converging lines of evidence argue against iron supplementation in schizophrenia patients with active neuroinflammation:
1. Fenton Chemistry and Oxidative Damage#
Iron catalyzes Fenton reactions (iron(II) (Fe2+) + H2O2 → iron(III) + OH- + OH-) generating hydroxyl radicals that damage dopaminergic neurons. Polyphenols' therapeutic benefit in schizophrenia derives partly from iron chelation—reducing iron-mediated oxidative stress. The therapeutic direction is iron restriction, not supplementation.[1]Plant-Derived Polyphenolic Compounds for Managing Schizophrenia: Mechanisms and Therapeutic PotentialJi X, Chai J, Zhao S et al. · 2025Open reference 1 ↓
2. Siderophore-Producing Pathobiont Bloom#
Enterobacteriaceae are significantly enriched in schizophrenia (systematic review of 30 studies,[2]Alterations of the Gut Microbiota in Patients with SchizophreniaLi Z, Tao X, Wang D et al. · 2024Open reference 2 ↓). These organisms produce siderophores for iron scavenging. Supplemental iron feeds this competitive advantage, worsening the dysbiotic bloom and increasing LPS production.
3. Nutritional Immunity Misinterpretation#
With 28% of schizophrenia patients showing elevated CRP (OR 1.5 for psychosis,[3]Immune System Abnormalities in Schizophrenia: An Integrative View and Translational PerspectivesErmakov EA, Melamud MM, Buneva VN et al. · 2022Open reference 3 ↓), low serum iron may represent hepcidin-mediated iron sequestration—a host defense mechanism to starve iron-dependent pathogens. Supplementing iron in this context overrides the host's own defense strategy.
Alternative Approach#
- Measure CRP alongside iron panels. If CRP is elevated, interpret low serum iron as potential nutritional immunity.
- Consider Lactoferrin supplementation—sequesters iron from pathogens while supporting host iron absorption through lactoferrin receptors.
- Consider polyphenol supplementation (curcumin, EGCG, quercetin) for therapeutic iron chelation.[1]Plant-Derived Polyphenolic Compounds for Managing Schizophrenia: Mechanisms and Therapeutic PotentialJi X, Chai J, Zhao S et al. · 2025Open reference 1 ↓
- Address the underlying inflammation driving the iron sequestration.
References 3
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Ji X, Chai J, Zhao S et al. (2025). Plant-Derived Polyphenolic Compounds for Managing Schizophrenia: Mechanisms and Therapeutic Potential. Frontiers in Pharmacology.
- 2
Li Z, Tao X, Wang D et al. (2024). Alterations of the Gut Microbiota in Patients with Schizophrenia. Frontiers in Psychiatry.
- 3
Ermakov EA, Melamud MM, Buneva VN et al. (2022). Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives. Frontiers in Psychiatry.
Article network
Mentioned here 2
Pages linking here 1
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +1 −1
Inspect exact Git diff ↗ - published revision
semantic integrity pass: boundary fixes, 10 interventions, 31 STOPs, 2 supersessions, keystone revalidation
WikiBiome Deploy Bot · +29 −0
Inspect exact Git diff ↗ - published revision
Deepen metal/concept entities + 8 new sources for T1D/schizophrenia
WikiBiome Deploy Bot · +2 −2
Inspect exact Git diff ↗ - published revision
Deep content + citation pass: 10 entities enriched, 7 new sources, DOI integrity
WikiBiome Deploy Bot · +0 −56
Inspect exact Git diff ↗ - published revision
Adversarial audit fixes: confidence downgrades, disclaimers, STOP safety, entity cleanup
WikiBiome Deploy Bot · +14 −11
Inspect exact Git diff ↗ - published revision
Tier 1 new condition signatures: schizophrenia, ovarian cancer, CKD, GERD
WikiBiome Deploy Bot · +56 −0
Inspect exact Git diff ↗ - published revision
Tier 1 new condition signatures: schizophrenia, ovarian cancer, CKD, GERD
WikiBiome Deploy Bot · +56 −0
Inspect exact Git diff ↗

